CC2019: Current Management Strategies for the Child with Intestinal Failure (PEDS)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Pediatric Surgery. Learn more about ACS Accreditation/Verification Requirements.
This session will be a panel discussion addressing the current status of children with intestinal failure. The panel will discuss updates in treatment and management of intestinal failure, including issues encountered with establishing an intestinal rehab program, bowel-lengthening procedures, new parenteral nutrition strategies, and the status of pediatric intestinal transplantation for intestinal failure. This panel will primarily focus on topics of interest to transplant and pediatric surgeons.
Moderator: Samuel M. Alaish, MD, FACS, Baltimore, MD
Co-Moderator: Colin A. Martin, MD, FACS, Birmingham, AL
Establishing an Intestinal Rehabilitation Program
Michael A. Helmrath, MD, FACS, Cincinnati, OH
Robert A. Cowles, MD, FACS, New Haven, CT
New Parenteral Nutrition Strategies
Meghan A. Arnold, MD, FACS, Ann Arbor, MI
The Status of Pediatric Intestinal Transplantation
David F. Mercer, MD, PhD, FACS, Omaha, NE
Sponsored by the Advisory Council for Pediatric Surgery
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
For questions about the course, please contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures).
Faculty and Disclosures
Colin A. Martin MD, FACS - Nothing to Disclose
David F. Mercer, MD, PhD, FACS - Takeda Pharmaceuticals: Research support: PI; Zealand Pharmaceuticals: Research support: PI and consultant for study design
Meghan A. Arnold MD, FACS - Nothing to Disclose
Michael A. Helmrath MD, FACS - Nothing to Disclose
Robert A. Cowles MD, FACS - Nothing to Disclose
Samuel M. Alaish MD, FACS - Nothing to Disclose
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure
David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure
Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Self Assessment Credit
- 1.50 Certificate of Completion